Matrix Private Capital Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,843
Closed -$224K 140
2025
Q1
$224K Sell
8,843
-147
-2% -$3.85K 0.13% 92
2024
Q4
$239K Sell
8,990
-149
-2% -$4.04K 0.14% 101
2024
Q3
$264K Sell
9,139
-100
-1% -$2.92K 0.15% 89
2024
Q2
$259K Sell
9,239
-178
-2% -$4.9K 0.16% 87
2024
Q1
$261K Sell
9,417
-51
-0.5% -$1.42K 0.18% 86
2023
Q4
$273K Sell
9,468
-3,301
-26% -$99.8K 0.21% 82
2023
Q3
$424K Buy
12,769
+1
+0% +$35 0.32% 54
2023
Q2
$468K Sell
12,768
-225
-2% -$8.76K 0.34% 53
2023
Q1
$530K Sell
12,993
-268
-2% -$11.6K 0.37% 52
2022
Q4
$679K Sell
13,261
-123
-0.9% -$5.9K 0.44% 48
2022
Q3
$586K Sell
13,384
-7,506
-36% -$365K 0.4% 51
2022
Q2
$1.09M Buy
20,890
+728
+4% +$37.1K 0.62% 34
2022
Q1
$1.04M Buy
20,162
+182
+0.9% +$9.44K 0.51% 43
2021
Q4
$1.18M Buy
19,980
+662
+3% +$32.8K 0.56% 38
2021
Q3
$831K Buy
19,318
+454
+2% +$20.1K 0.44% 55
2021
Q2
$739K Sell
18,864
-1,820
-9% -$70.8K 0.4% 60
2021
Q1
$749K Buy
20,684
+2,056
+11% +$73K 0.45% 59
2020
Q4
$686K Buy
18,628
+1,342
+8% +$49.2K 0.49% 53
2020
Q3
$602K Buy
17,286
+4,549
+36% +$159K 0.61% 48
2020
Q2
$395K Buy
12,737
+400
+3% +$13.6K 0.44% 70
2020
Q1
$382K Buy
12,337
+4,234
+52% +$144K 0.54% 54
2019
Q4
$301K Buy
+8,103
New +$289K 0.32% 97

Other funds holding PFE

Matrix Private Capital Group's PFE Position: Q2 2025 in Review

Matrix Private Capital Group sold out of Pfizer (PFE) in Q2 2025, closing a stake of 8,843 shares — an estimated $224K sold.

Matrix Private Capital Group first reported a position in PFE in Q4 2019 and held it in 22 quarters. The position peaked at $1.18M in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Matrix Private Capital Group reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Matrix Private Capital Group sold 8,843 Pfizer shares in Q2 2025, an estimated $224K.
  • Matrix Private Capital Group first reported a position in Pfizer in Q4 2019 and held it in 22 quarters.
  • Matrix Private Capital Group's Pfizer position peaked at $1.18M in Q4 2021.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Matrix Private Capital Group's 13F filing for Q2 2025, filed 14 Aug 2025.